BRIEF published on 06/11/2025 at 08:55, 8 months ago SCHOTT Pharma prolonge le contrat de son PDG et nomme un nouveau directeur financier Expansion Mondiale Prolongation Du Contrat Du PDG Nomination D'un Nouveau Directeur Financier Confinement Pharmaceutique Leadership Innovant
BRIEF published on 06/11/2025 at 08:55, 8 months ago SCHOTT Pharma Extends CEO Contract and Appoints New CFO Global Expansion CEO Contract Extension Innovative Leadership New CFO Appointment Pharmaceutical Containment
PRESS RELEASE published on 06/11/2025 at 08:50, 8 months ago SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO SCHOTT Pharma extends CEO's contract Andreas Reisse & appoints Reinhard Mayer as CFO. Strategic personnel changes at SCHOTT Pharma AG & Co. KGaA CFO Appointment SCHOTT Pharma Personnel Changes CEO Contract Reinhard Mayer
BRIEF published on 06/04/2025 at 15:35, 8 months 7 days ago SCHOTT Pharma étend sa production de cartouches stériles en Hongrie Expansion SCHOTT Pharma Pharmaceutique Hongrie Cartouches Stériles
BRIEF published on 06/04/2025 at 15:35, 8 months 7 days ago SCHOTT Pharma Expands Sterile Cartridge Production in Hungary Expansion Pharmaceutical SCHOTT Pharma Hungary Sterile Cartridges
PRESS RELEASE published on 06/04/2025 at 15:30, 8 months 7 days ago SCHOTT Pharma invests in sterile cartridge production in Hungary SCHOTT Pharma invests over EUR 100 million in new sterile cartridge production facility in Hungary to meet market demand for high-value solutions Expansion Investment SCHOTT Pharma Hungary Sterile Cartridge Production
BRIEF published on 05/15/2025 at 07:05, 8 months 27 days ago SCHOTT Pharma Reports Strong Q2 2025 Performance Revenue Growth SCHOTT Pharma High-value Solutions Pharmaceutical Innovations Q2 2025 Results
BRIEF published on 05/15/2025 at 07:05, 8 months 27 days ago SCHOTT Pharma annonce de solides performances au deuxième trimestre 2025 SCHOTT Pharma Croissance Des Revenus Des Solutions À Forte Valeur Ajoutée Résultats Du Deuxième Trimestre 2025 Innovations Pharmaceutiques
PRESS RELEASE published on 05/15/2025 at 07:00, 8 months 27 days ago SCHOTT Pharma delivers strong second quarter of fiscal year 2025 SCHOTT Pharma AG & Co. KGaA reports strong Q2 2025 results with 8% revenue growth and 28.6% EBITDA margin. High-value solutions drive growth in pharmaceutical industry Pharmaceutical Industry Revenue Growth SCHOTT Pharma High-value Solutions Q2 2025
BRIEF published on 05/06/2025 at 07:05, 9 months 5 days ago TPG's Strategic Investment in SCHOTT Poonawalla Enhances Joint Venture Growth Joint Venture SCHOTT Pharma India Market Serum Institute TPG Investment
Published on 02/11/2026 at 14:35, 1 hour 1 minute ago Worksport Delivers Breakout Q4: Revenue Up 65% YoY, Gross Profit Up 380%
Published on 02/11/2026 at 14:30, 1 hour 6 minutes ago Sekur Private Data CEO Updates on Growth, Market Expansion, Corporate Developments and New Product Launch
Published on 02/11/2026 at 14:00, 1 hour 36 minutes ago Organto Foods Inc. Expands Scalable and Flexible Logistics Platform to Support 2026 Growth
Published on 02/11/2026 at 14:00, 1 hour 36 minutes ago PPX Mining Provides Operational and Corporate Update
Published on 02/11/2026 at 14:00, 1 hour 36 minutes ago Meta Critical Minerals Engages Quad Consulting Group to Advance Table Mountain Silica Project Development Strategy
Published on 02/11/2026 at 15:03, 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 02/11/2026 at 14:59, 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 02/11/2026 at 11:25, 4 hours 10 minutes ago Innelec : Mise à disposition du rapport financier semestriel 2025-26
Published on 02/11/2026 at 08:00, 7 hours 36 minutes ago Imerys-press-release French State acquisition stake Emili Lithium
Published on 02/11/2026 at 08:00, 7 hours 36 minutes ago Imerys-communique-de-presse prise participation Etat Français Projet lithium Emili
Published on 02/10/2026 at 18:24, 21 hours 11 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 21 hours 11 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
